(Q37039444)

17 August 2017

1 reference

title

Cognitive impairment in Parkinson's disease and dementia with lewy bodies: a spectrum of disease (English)

1 reference

dementia with Lewy bodies

17 August 2017

0 references

1 reference

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

2

Andrew Siderowf

1 reference

17 August 2017

author name string

Rachel Goldmann Gross

series ordinal

1

1 reference

17 August 2017

Howard I Hurtig

series ordinal

3

1 reference

17 August 2017

publication date

5 December 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

16

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

24-34

1 reference

An Essay on the Shaking Palsy

17 August 2017

cites work

1 reference

Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.

21 January 2018

1 reference

Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study.

21 January 2018

1 reference

Mortality from Parkinson disease.

21 January 2018

1 reference

Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?

21 January 2018

1 reference

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers

21 January 2018

1 reference

Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.

21 January 2018

1 reference

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group

21 January 2018

1 reference

Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease

21 January 2018

1 reference

Fluctuations in cognition and alertness in Parkinson's disease and dementia

21 January 2018

1 reference

Cognitive conditions of pathologically confirmed dementia with Lewy bodies and Parkinson's disease with dementia

21 January 2018

1 reference

Cognitive, affective, and psychiatric features of Parkinson's disease

21 January 2018

1 reference

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

21 January 2018

1 reference

Prevalence of dementia with Lewy bodies in an inpatient psychogeriatric population in Hong Kong Chinese.

21 January 2018

1 reference

Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei.

21 January 2018

1 reference

Is dementia with Lewy bodies the second most common cause of dementia?

21 January 2018

1 reference

Cognitive profile of patients with newly diagnosed Parkinson disease.

21 January 2018

1 reference

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study

21 January 2018

1 reference

Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson's disease.

21 January 2018

1 reference

A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease.

21 January 2018

1 reference

Antecedent clinical features associated with dementia in Parkinson's disease

21 January 2018

1 reference

Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions

21 January 2018

1 reference

Predictors of cognitive impairment in advanced Parkinson's disease

21 January 2018

1 reference

Visual perception in Parkinson disease dementia and dementia with Lewy bodies.

21 January 2018

1 reference

Attentional resource and processing speed limitations during sentence processing in Parkinson's disease.

21 January 2018

1 reference

Dimensions of executive function in Parkinson's disease.

21 January 2018

1 reference

What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?

21 January 2018

1 reference

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

Lewy body cortical involvement may not always predict dementia in Parkinson's disease

21 January 2018

1 reference

Differences in neuropathologic characteristics across the Lewy body dementia spectrum.

21 January 2018

1 reference

Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response

21 January 2018

1 reference

Diagnosis and treatment of Parkinson disease: molecules to medicine

21 January 2018

1 reference

HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS

21 January 2018

1 reference

Metabolic brain networks associated with cognitive function in Parkinson's disease

21 January 2018

1 reference

Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics

21 January 2018

1 reference

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease

21 January 2018

1 reference

Molecular markers of early Parkinson's disease based on gene expression in blood

21 January 2018

1 reference

(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis

21 January 2018

1 reference

Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.

21 January 2018

1 reference

Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways

21 January 2018

1 reference

Imaging beta-amyloid burden in aging and dementia.

21 January 2018

1 reference

[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.

21 January 2018

1 reference

Olfaction in neurodegenerative disorder

21 January 2018

1 reference

Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease

21 January 2018

1 reference

Association of dopamine agonist use with impulse control disorders in Parkinson disease

21 January 2018

1 reference

Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies.

21 January 2018

1 reference

Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease

21 January 2018

1 reference

Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.

21 January 2018

1 reference

Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study

21 January 2018

1 reference

Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies

21 January 2018

1 reference

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

21 January 2018

1 reference

Worsening of motor function and mood in a patient with Parkinson's disease after pharmacologic challenge with oral rivastigmine

21 January 2018

1 reference

Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration.

21 January 2018

1 reference

Neuropathology of dementia in Parkinson's disease: A prospective, community-based study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000109756

1 reference

17 August 2017

1 reference